Status:
UNKNOWN
Epidemiological Study on Malignancy Complicated With Renal Injury
Lead Sponsor:
RenJi Hospital
Conditions:
Kidney Injury
Eligibility:
All Genders
18-80 years
Brief Summary
The epidemiological study of tumor complicated with kidney disease can clarify the prevalence and risk factors of renal injury when malignant tumor is diagnosed, and understand the impact of malignant...
Detailed Description
1. To determine the prevalence of malignant tumor complicated with renal injury and analyze the related risk factors. 2. To compare the survival time of malignant tumor with or without renal injury
Eligibility Criteria
Inclusion
- Malignancy confirmed by pathology.
- Between 18-80 years old, regardless of gender; Patients initially diagnosed with malignant tumors in our hospital from July 2017 to June 2021; Waiver of informed consent.
Exclusion
- Patients with benign tumor diagnosed by pathology; The patient refused to participate; Patients judged by other researchers as unsuitable for inclusion in the study.
Key Trial Info
Start Date :
December 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
30000 Patients enrolled
Trial Details
Trial ID
NCT05392725
Start Date
December 1 2022
End Date
December 1 2024
Last Update
May 26 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.